|
|
negative regulation of nlrp3 inflammasome complex assembly
|
GO:1900226 |
2 |
0.324
|
|
|
|
entry into host
|
GO:0044409 |
15 |
0.301
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.297
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.286
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.264
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.245
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.230
|
|
|
|
entry into cell of other organism involved in symbiotic interaction
|
GO:0051806 |
15 |
0.200
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.188
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.168
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.158
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.153
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.150
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.139
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.138
|
|
|
|
mrna 3 end processing
|
GO:0031124 |
16 |
0.132
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.114
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.111
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.110
|
|
|
|
ribonucleoprotein complex subunit organization
|
GO:0071826 |
28 |
0.101
|
|
|
|
transcription from rna polymerase iii promoter
|
GO:0006383 |
3 |
0.097
|
Yeast |
|
|
regulation of nlrp3 inflammasome complex assembly
|
GO:1900225 |
4 |
0.092
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.091
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.089
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.088
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.085
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.084
|
|
|
|
regulation of histone h3 k4 methylation
|
GO:0051569 |
12 |
0.083
|
|
|
|
movement in environment of other organism involved in symbiotic interaction
|
GO:0052192 |
15 |
0.083
|
|
|
|
epithalamus development
|
GO:0021538 |
2 |
0.078
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.077
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.067
|
Human |
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.067
|
|
|
|
positive regulation of viral entry into host cell
|
GO:0046598 |
3 |
0.067
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.066
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.063
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.063
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.062
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.062
|
Yeast |
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.061
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.060
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.059
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.059
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.058
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.058
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.057
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.055
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.055
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.054
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.053
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.053
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.051
|
|
|
|
viral life cycle
|
GO:0019058 |
36 |
0.051
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.050
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.049
|
|
|
|
histone h4 k16 acetylation
|
GO:0043984 |
3 |
0.049
|
|
|
|
regulation of response to drug
|
GO:2001023 |
2 |
0.049
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.048
|
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
40 |
0.048
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.048
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.048
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.047
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.046
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.045
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.044
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.044
|
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.044
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.043
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.042
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.041
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.041
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.041
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.039
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.039
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.039
|
|
|
|
histone h3 k4 trimethylation
|
GO:0080182 |
5 |
0.038
|
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.038
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.037
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.037
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.037
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.036
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.035
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.035
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.035
|
|
|
|
movement in host environment
|
GO:0052126 |
15 |
0.035
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.034
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.034
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.034
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.033
|
|
|
|
regulation of actin nucleation
|
GO:0051125 |
4 |
0.033
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.033
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.033
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.033
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.033
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.032
|
|
|
|
viral entry into host cell
|
GO:0046718 |
15 |
0.032
|
|
|
|
catecholamine secretion
|
GO:0050432 |
15 |
0.032
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.032
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.032
|
|
|
|
entry into other organism involved in symbiotic interaction
|
GO:0051828 |
15 |
0.032
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.031
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.031
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.030
|
|
|
|
habenula development
|
GO:0021986 |
2 |
0.030
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.030
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.030
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.030
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.029
|
|
|
|
negative regulation of viral transcription
|
GO:0032897 |
3 |
0.029
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.029
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.028
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.028
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.028
|
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.028
|
Human |
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.028
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.028
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.028
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.028
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.027
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.027
|
|
|
|
rna 3 end processing
|
GO:0031123 |
20 |
0.027
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.027
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.027
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.027
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.027
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.027
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.026
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.026
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.026
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.026
|
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.026
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.026
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.026
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.025
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.025
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.025
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.025
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.025
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.025
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.025
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.025
|
|
|
|
histone h4 acetylation
|
GO:0043967 |
10 |
0.025
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.024
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.024
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.024
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.024
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.024
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.024
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.024
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.024
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.024
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.024
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.024
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.024
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.024
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.024
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.024
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.024
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.023
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.023
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.023
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.023
|
|
|
|
interaction with host
|
GO:0051701 |
22 |
0.023
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.023
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.023
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.023
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.022
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.022
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.022
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.022
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.022
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.022
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.022
|
|
|
|
negative regulation of interleukin 6 production
|
GO:0032715 |
17 |
0.022
|
|
|
|
retrograde transport endosome to golgi
|
GO:0042147 |
2 |
0.022
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.021
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.021
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.021
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.021
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.021
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.021
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.021
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.021
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.021
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.020
|
|
|
|
cellular hyperosmotic salinity response
|
GO:0071475 |
0 |
0.020
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.020
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.020
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.020
|
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
43 |
0.020
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.020
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.019
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.019
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.019
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.019
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.019
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.019
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.019
|
|
|
|
rhombomere morphogenesis
|
GO:0021593 |
2 |
0.019
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.019
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.019
|
|
|
|
oligodendrocyte development
|
GO:0014003 |
20 |
0.019
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.019
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.019
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.018
|
|
|
|
regulation of response to biotic stimulus
|
GO:0002831 |
38 |
0.018
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.018
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.018
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.018
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.018
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.018
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.018
|
|
|
|
negative regulation of chromatin silencing
|
GO:0031936 |
1 |
0.018
|
|
|
|
embryonic viscerocranium morphogenesis
|
GO:0048703 |
8 |
0.018
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.018
|
|
|
|
histone h3 k4 methylation
|
GO:0051568 |
23 |
0.018
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.018
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.018
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.018
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.018
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.018
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.018
|
|
|
|
negative regulation of protein targeting to membrane
|
GO:0090315 |
1 |
0.018
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.018
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.018
|
|
|
|
glycolytic process
|
GO:0006096 |
20 |
0.018
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.017
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.017
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.017
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.017
|
|
|
|
regulation of rna splicing
|
GO:0043484 |
37 |
0.017
|
Human |
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.017
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.017
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.017
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.017
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.017
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.017
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.017
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.016
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.016
|
|
|
|
nuclear transcribed mrna catabolic process nonsense mediated decay
|
GO:0000184 |
1 |
0.016
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.016
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.016
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.016
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.016
|
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.016
|
|
|
|
wnt signaling pathway planar cell polarity pathway
|
GO:0060071 |
27 |
0.016
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.016
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.016
|
|
|
|
histone deubiquitination
|
GO:0016578 |
2 |
0.016
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.016
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.016
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.016
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.016
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.015
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.015
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.015
|
|
|
|
positive regulation of actin nucleation
|
GO:0051127 |
3 |
0.015
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.015
|
|
|
|
proprioception
|
GO:0019230 |
4 |
0.015
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.015
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.015
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.015
|
|
|
|
membrane fusion
|
GO:0061025 |
38 |
0.015
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.015
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.015
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.015
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.015
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.015
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.015
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.015
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.015
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.015
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.014
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.014
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.014
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.014
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.014
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.014
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.014
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.014
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.014
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.014
|
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.014
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.014
|
|
|
|
viral transcription
|
GO:0019083 |
3 |
0.014
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.014
|
|
|
|
regulation of transcription during meiosis
|
GO:0051037 |
1 |
0.014
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
49 |
0.014
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.014
|
|
|
|
toll like receptor signaling pathway
|
GO:0002224 |
38 |
0.014
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.014
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.014
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.014
|
|
|
|
protein homotrimerization
|
GO:0070207 |
4 |
0.013
|
|
|
|
ascending thin limb development
|
GO:0072021 |
2 |
0.013
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.013
|
|
|
|
schwann cell differentiation
|
GO:0014037 |
26 |
0.013
|
|
|
|
regulation of ral protein signal transduction
|
GO:0032485 |
4 |
0.013
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.013
|
|
|
|
telomere capping
|
GO:0016233 |
4 |
0.013
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.013
|
|
|
|
regulation of defense response to virus
|
GO:0050688 |
18 |
0.013
|
|
|
|
midbrain development
|
GO:0030901 |
35 |
0.013
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.013
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.013
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.013
|
|
|
|
regulation of toll like receptor signaling pathway
|
GO:0034121 |
20 |
0.013
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.013
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.013
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.013
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.013
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.013
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.013
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.013
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.013
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.013
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.013
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.013
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.013
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.013
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.013
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.012
|
|
|
|
memory
|
GO:0007613 |
58 |
0.012
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.012
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.012
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.012
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.012
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
29 |
0.012
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.012
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.012
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.012
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.012
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.012
|
|
|
|
stem cell division
|
GO:0017145 |
30 |
0.012
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.012
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.012
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.012
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.012
|
|
|
|
negative regulation of tumor necrosis factor production
|
GO:0032720 |
17 |
0.011
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.011
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.011
|
|
|
|
interferon beta production
|
GO:0032608 |
16 |
0.011
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.011
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.011
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.011
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.011
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.011
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.011
|
Human |
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.011
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.011
|
|
|
|
rna phosphodiester bond hydrolysis exonucleolytic
|
GO:0090503 |
4 |
0.011
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.011
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.011
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.011
|
|
|
|
schwann cell development
|
GO:0014044 |
22 |
0.011
|
|
|
|
entry into host cell
|
GO:0030260 |
15 |
0.011
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.011
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.011
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.011
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.011
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.011
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.011
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.011
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.011
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.011
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.011
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.011
|
|
|
|
intracellular distribution of mitochondria
|
GO:0048312 |
1 |
0.011
|
|
|
|
gluconeogenesis
|
GO:0006094 |
39 |
0.011
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.011
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.011
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.011
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.011
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.011
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.011
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.011
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.011
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.011
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.011
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.011
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.011
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.011
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.011
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.010
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.010
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.010
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.010
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.010
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.010
|
|
|
|
defense response to gram negative bacterium
|
GO:0050829 |
28 |
0.010
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.010
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.010
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.010
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.010
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.010
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.010
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
47 |
0.010
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.010
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.010
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.010
|
Mouse |
